<p>, /PRNewswire/ -- JND 法律管理</p>
<p><strong>特拉华州衡平法院</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>MILANA NEMETH 和 ADAM SAAB，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>代表他们自己及所有类似情况的其他人，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>原告，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>v.</td>
<td></td>
<td></td>
</tr>
<tr>
<td>ELI D. CASDIN, KEITH A. MEISTER，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CHRISTIAN HENRY, KWAME OWUSU-</td>
<td></td>
<td></td>
</tr>
<tr>
<td>KESSE, CHAD ROBINS, HARLAN ROBINS，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>AMY ABERNETHY, BRIAN EMES, SHAUN</td>
<td></td>
<td></td>
</tr>
<tr>
<td>RODRIGUEZ, CMLS HOLDINGS III LLC，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CORVEX MANAGEMENT LP, CASDIN</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CAPITAL, LLC, REVOLUTION MEDICINES，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>INC. 和 ALEXIS BORISY，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>被告。</td>
<td>)</td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td>C.A. No. 2024-1268-PAF</td>
<td></td>
</tr>
</tbody>
</table>
<p><strong>待决事项及拟议的</strong></p>
<p><strong>股东集体诉讼和解</strong></p>
<p><strong>听证会及出庭权利</strong></p>
<p><strong>致：</strong> <strong>所有 CM 生命科学 III 公司（&#34;CMLS III&#34;）A 类普通股的记录和实益持有者，他们在 2021 年 12 月 14 日下午 5:00（东部时间）赎回截止日期后立即持有该股票，包括通过法律操作获得股份的继承人</strong></p>
<p><strong>本通知经特拉华州衡平法院（&#34;法院&#34;）授权。此通知不是律师招揽。请仔细阅读本通知及其全部内容。您的权利将受到正在法院进行的集体诉讼的影响。</strong></p>
<p>根据法院的命令和衡平法院规则第 23 条，特此通知您：(i) 上述标题的诉讼（&#34;诉讼&#34;）已初步认证为代表所有 CMLS III A 类普通股（&#34;A 类普通股&#34;）的记录和实益持有者的集体诉讼，包括通过法律操作获得股份的继承人，但不包括某些被排除人员（&#34;集体&#34;）；(ii) 原告和诉讼中的被告已达成协议，以 725 万美元现金（&#34;和解&#34;）解决诉讼。如果和解获得批准，将解决诉讼中的所有索赔。本摘要通知中使用的任何大写术语，如未在此处另行定义，应具有在 2026 年 1 月 5 日签署的妥协、和解和解除协议（&#34;协议&#34;）及股东集体诉讼、和解听证会及出庭权利的待决事项和拟议和解通知（&#34;通知&#34;）中赋予的含义，副本可在 www.cmlsiiistockholdersettlement.com 获取。</p>
<p>听证会将于 2026 年 4 月 21 日下午 1:30 在特拉华州衡平法院，由尊敬的保罗·A·菲奥拉万提副法官主持，地点为莱昂纳德·L·威廉姆斯司法中心，北金街 500 号，威尔明顿，DE 19801，目的是确定：(i) 是否仅为和解目的最终认证集体，依据衡平法院规则 23(a)、23(b)(1) 和 23(b)(2)；(ii) 原告和原告律师是否充分代表集体，原告是否应最终被任命为集体代表，原告律师是否应最终被任命为集体律师；(iii) 拟议的和解是否应被批准为公平、合理且对原告及其他集体成员的最佳利益；(iv) 是否应根据协议进入批准和解、以偏见驳回诉讼并授予协议下的解除的拟议命令和最终判决；(v) 拟议的净和解基金分配计划是否公平合理，因此应获得批准；(vi) 是否以及以何种金额应从和解基金中支付任何费用和支出奖励给原告律师，包括任何服务奖励仅从任何费用和支出奖励中支付给原告；(vii) 听取并裁定对和解、拟议的分配计划、原告律师申请费用和支出奖励及/或任何服务奖励的任何异议；(viii) 考虑与和解相关的任何其他事项。</p>
<p>如果您在 2021 年 12 月 14 日持有 CMLS III A 类普通股，无论是记录持有还是实益持有，您的权利可能会受到本诉讼和解的影响。如果您尚未收到详细通知和索赔及解除证明表（&#34;索赔证明&#34;）的副本，您可以通过写信至 CMLS III 股东和解，和解管理员，JND 法律管理，邮政信箱 91222，西雅图，WA 98111，或在 www.cmlsiiistockholdersettlement.com 下载此信息来获取副本。如果您是集体成员，为了分享净和解基金的分配，您必须在 <strong>2026 年 5 月 25 日</strong> 之前在线提交索赔证明，或通过邮寄方式在 <strong>2026 年 5 月 25 日</strong> 之前送达，以证明您有权获得赔偿。1</p>
<p>该集体是根据衡平法院规则 23(a)、23(b)(1) 和 23(b)(2) 的非&#34;选择退出&#34;集体。因此，集体成员将受限于根据协议条款和条件在诉讼中作出的任何判决。</p>
<p>对和解的任何异议必须在以下地址向衡平法院登记处提交，并送达原告律师和被告律师（通过 File &amp; Serve _Xpress_电子方式、亲自、通过美国邮政一类邮件、快递服务或电子邮件）至以下地址，确保在 <strong>2026 年 4 月 7 日</strong> 之前收到：</p>
<p><strong>衡平法院登记处</strong></p>
<p>衡平法院登记处</p>
<p>特拉华州衡平法院</p>
<p>莱昂纳德·L·威廉姆斯司法中心</p>
<p>北金街 500 号</p>
<p>威尔明顿，DE 19801</p>
<p><strong>原告律师</strong></p>
<p>格雷戈里·E·德尔·盖佐</p>
<p>罗宾斯律师事务所</p>
<p>5060 Shoreham Place, Suite 300</p>
<p>圣地亚哥，CA 92122</p>
<p>[email protected]</p>
<p>凯莉·L·塔克</p>
<p>格兰特与艾森霍弗律师事务所</p>
<p>德拉瓦州威明顿市 123 Justison Street, 7 楼</p>
<p>邮政编码 19801</p>
<p>[email protected]</p>
<p><strong>被告律师</strong></p>
<p>德博拉·S·伯恩巴赫</p>
<p>Goodwin Procter LLP</p>
<p>北大道 100 号</p>
<p>马萨诸塞州波士顿 02210</p>
<p>[email protected]</p>
<p>格雷戈里·斯塔纳</p>
<p>美洲大道 1221 号</p>
<p>纽约市，纽约州 10020</p>
<p>[email protected]</p>
<p><strong>请勿就此通知联系法院、注册官、被告或被告律师</strong>。如果您对和解有任何疑问，可以通过上述地址联系原告的律师，拨打电话 (302) 622-7000 或 (619) 525-3990，或访问以下网站：www.cmlsiiistockholdersettlement.com。</p>
<p>根据德拉瓦州衡平法院的命令</p>
<p>1 证明索赔的邮戳日期不得晚于 <strong>2026 年 5 月 25 日</strong>，将视为在邮戳日期收到。请注意，美国邮政服务可能不会对未亲自递交的邮件进行邮戳。</p>
<p>来源 JND 法律行政管理</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEzJk5ld3NJdGVtSWQ9TEE3NjgzOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTMwOTEzUFJfTkVXU19VU1BSX19fX19MQTc2ODM4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEzJk5ld3NJdGVtSWQ9TEE3NjgzOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTMwOTEzUFJfTkVXU19VU1BSX19fX19MQTc2ODM4"/></p>

基因免疫&健康关怀 ETF - iShares

纳斯达克生物科技指数 ETF - iShares Nasdaq

生物科技 ETF - VanEck Vectors

标普生物技术 ETF - SPDR

2 倍做多纳斯达克生物技术 ETF - ProShares

纽交所高增长板生物技术指数 ETF - First Trust

动态生物技术与基因组 ETF - Invesco

OLSI

MDLS

<p>CM Life Sciences III, Inc. A 类普通股股东集体诉讼的待决通知和拟议和解。已提议一项 725 万美元的和解，影响截至 2021 年 12 月 14 日的所有登记和实际持有该股票的股东。听证会定于 2026 年 4 月 21 日举行，以决定和解及相关事项的批准。集体成员必须提交索赔证明以参与和解基金的分配</p>

<p>, /PRNewswire/ -- JND Legal Administration</p>
<div class="lb-trans"><p>, /PRNewswire/ -- JND 法律管理</p>
</div><p><strong>IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</strong></p>
<div class="lb-trans"><p><strong>特拉华州衡平法院</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>MILANA NEMETH and ADAM SAAB,<br/>individually on behalf of themselves and all<br/>others similarly situated,<br/>Plaintiffs,<br/>v.<br/>ELI D. CASDIN, KEITH A. MEISTER,<br/>CHRISTIAN HENRY, KWAME OWUSU-<br/>KESSE, CHAD ROBINS, HARLAN ROBINS,<br/>AMY ABERNETHY, BRIAN EMES, SHAUN<br/>RODRIGUEZ, CMLS HOLDINGS III LLC,<br/>CORVEX MANAGEMENT LP, CASDIN<br/>CAPITAL, LLC, REVOLUTION MEDICINES,<br/>INC., and ALEXIS BORISY,<br/>Defendants.</td>
<td>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)<br/>)</td>
<td>C.A. No. 2024-1268-PAF</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>MILANA NEMETH 和 ADAM SAAB，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>代表他们自己及所有类似情况的其他人，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>原告，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>v.</td>
<td></td>
<td></td>
</tr>
<tr>
<td>ELI D. CASDIN, KEITH A. MEISTER，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CHRISTIAN HENRY, KWAME OWUSU-</td>
<td></td>
<td></td>
</tr>
<tr>
<td>KESSE, CHAD ROBINS, HARLAN ROBINS，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>AMY ABERNETHY, BRIAN EMES, SHAUN</td>
<td></td>
<td></td>
</tr>
<tr>
<td>RODRIGUEZ, CMLS HOLDINGS III LLC，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CORVEX MANAGEMENT LP, CASDIN</td>
<td></td>
<td></td>
</tr>
<tr>
<td>CAPITAL, LLC, REVOLUTION MEDICINES，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>INC. 和 ALEXIS BORISY，</td>
<td></td>
<td></td>
</tr>
<tr>
<td>被告。</td>
<td>)</td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>)</td>
<td>C.A. No. 2024-1268-PAF</td>
<td></td>
</tr>
</tbody>
</table>
</div><p><strong>SUMMARY NOTICE OF PENDENCY AND PROPOSED</strong></p>
<div class="lb-trans"><p><strong>待决事项及拟议的</strong></p>
</div><p><strong>SETTLEMENT OF STOCKHOLDER CLASS ACTION, SETTLEMENT</strong></p>
<div class="lb-trans"><p><strong>股东集体诉讼和解</strong></p>
</div><p><strong>HEARING, AND RIGHT TO APPEAR</strong></p>
<div class="lb-trans"><p><strong>听证会及出庭权利</strong></p>
</div><p><strong>TO:</strong> <strong>ALL RECORD AND BENEFICIAL HOLDERS OF CM LIFE SCIENCES III, INC. (&#34;CMLS III&#34;) CLASS A COMMON STOCK WHO HELD SUCH STOCK IMMEDIATELY FOLLOWING THE REDEMPTION DEADLINE OF 5:00 PM ET ON DECEMBER 14, 2021, INCLUDING THEIR SUCCESSORS IN INTEREST WHO OBTAINED SHARES BY OPERATION OF LAW</strong></p>
<div class="lb-trans"><p><strong>致：</strong> <strong>所有 CM 生命科学 III 公司（&#34;CMLS III&#34;）A 类普通股的记录和实益持有者，他们在 2021 年 12 月 14 日下午 5:00（东部时间）赎回截止日期后立即持有该股票，包括通过法律操作获得股份的继承人</strong></p>
</div><p><strong>THIS NOTICE WAS AUTHORIZED BY THE COURT OF CHANCERY OF THE STATE OF DELAWARE (THE &#34;COURT&#34;). IT IS NOT A LAWYER SOLICITATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THE COURT</strong>.</p>
<div class="lb-trans"><p><strong>本通知经特拉华州衡平法院（&#34;法院&#34;）授权。此通知不是律师招揽。请仔细阅读本通知及其全部内容。您的权利将受到正在法院进行的集体诉讼的影响。</strong></p>
</div><p>YOU ARE HEREBY NOTIFIED, pursuant to an Order of the Court and Court of Chancery Rule 23, that: (i) the above-captioned action (the &#34;Action&#34;) has been preliminarily certified as a class action on behalf of a class of all record and beneficial holders of CMLS III Class A Common Stock (&#34;Class A Common Stock&#34;) during the Class Period, including successors-in-interest who obtained shares by operation of law, but excluding certain Excluded Persons (the &#34;Class&#34;); and (ii) Plaintiffs and Defendants in the Action have reached an agreement to settle the Action for $7,250,000 in cash (the &#34;Settlement&#34;). If the Settlement is approved, it will resolve all claims in the Action. Any capitalized terms used in this Summary Notice that are not otherwise defined herein shall have the meanings ascribed to them in the Stipulation and Agreement of Compromise, Settlement, and Release dated January 5, 2026 (the &#34;Stipulation&#34;), and the Notice of Pendency and Proposed Settlement of Stockholder Class Action, Settlement Hearing, and Right to Appear (&#34;Notice&#34;), copies of which can be obtained at www.cmlsiiistockholdersettlement.com.</p>
<div class="lb-trans"><p>根据法院的命令和衡平法院规则第 23 条，特此通知您：(i) 上述标题的诉讼（&#34;诉讼&#34;）已初步认证为代表所有 CMLS III A 类普通股（&#34;A 类普通股&#34;）的记录和实益持有者的集体诉讼，包括通过法律操作获得股份的继承人，但不包括某些被排除人员（&#34;集体&#34;）；(ii) 原告和诉讼中的被告已达成协议，以 725 万美元现金（&#34;和解&#34;）解决诉讼。如果和解获得批准，将解决诉讼中的所有索赔。本摘要通知中使用的任何大写术语，如未在此处另行定义，应具有在 2026 年 1 月 5 日签署的妥协、和解和解除协议（&#34;协议&#34;）及股东集体诉讼、和解听证会及出庭权利的待决事项和拟议和解通知（&#34;通知&#34;）中赋予的含义，副本可在 www.cmlsiiistockholdersettlement.com 获取。</p>
</div><p>A hearing will be held on April 21, 2026, at 1:30 p.m., before the Honorable Paul A. Fioravanti, Vice Chancellor, at the Court of Chancery of the State of Delaware, Leonard L. Williams Justice Center, 500 North King Street, Wilmington, DE 19801, for the purpose of determining: (i) whether to finally certify the Class for settlement purposes only, pursuant to Court of Chancery Rules 23(a), 23(b)(1), and 23(b)(2); (ii) whether Plaintiffs and Plaintiffs' Counsel have adequately represented the Class, and whether Plaintiffs should be finally appointed as Class Representatives for the Class and Plaintiffs' Counsel should be finally appointed as Class Counsel for the Class; (iii) whether the proposed Settlement should be approved as fair, reasonable, and adequate to Plaintiffs and the other members of the Class and in their best interests; (iv) whether the proposed Order and Final Judgment approving the Settlement, dismissing the Action with prejudice, and granting the Releases provided under the Stipulation should be entered; (v) whether the proposed Plan of Allocation of the Net Settlement Fund is fair and reasonable, and should therefore be approved; (vi) whether and in what amount any Fee and Expense Award to Plaintiffs' Counsel should be paid out of the Settlement Fund, including any service award to Plaintiffs to be paid solely from any Fee and Expense Award; (vii) to hear and rule on any objections to the Settlement, the proposed Plan of Allocation, Plaintiffs' Counsel's application for a Fee and Expense Award, and/or any service award to Plaintiffs; and (viii) to consider any other matters that may properly be brought before the Court in connection with the Settlement.</p>
<div class="lb-trans"><p>听证会将于 2026 年 4 月 21 日下午 1:30 在特拉华州衡平法院，由尊敬的保罗·A·菲奥拉万提副法官主持，地点为莱昂纳德·L·威廉姆斯司法中心，北金街 500 号，威尔明顿，DE 19801，目的是确定：(i) 是否仅为和解目的最终认证集体，依据衡平法院规则 23(a)、23(b)(1) 和 23(b)(2)；(ii) 原告和原告律师是否充分代表集体，原告是否应最终被任命为集体代表，原告律师是否应最终被任命为集体律师；(iii) 拟议的和解是否应被批准为公平、合理且对原告及其他集体成员的最佳利益；(iv) 是否应根据协议进入批准和解、以偏见驳回诉讼并授予协议下的解除的拟议命令和最终判决；(v) 拟议的净和解基金分配计划是否公平合理，因此应获得批准；(vi) 是否以及以何种金额应从和解基金中支付任何费用和支出奖励给原告律师，包括任何服务奖励仅从任何费用和支出奖励中支付给原告；(vii) 听取并裁定对和解、拟议的分配计划、原告律师申请费用和支出奖励及/或任何服务奖励的任何异议；(viii) 考虑与和解相关的任何其他事项。</p>
</div><p>If you held shares of CMLS III Class A Common Stock, either of record or beneficially, as of December 14, 2021, your rights may be affected by the settlement of this Action. If you have not received a detailed Notice and a copy of the Proof of Claim and Release form (&#34;Proof of Claim&#34;), you may obtain copies (as well as a copy of the Stipulation) by writing to CMLS III Stockholder Settlement, Settlement Administrator, c/o JND Legal Administration, P.O. Box 91222, Seattle, WA 98111 or by downloading this information at www.cmlsiiistockholdersettlement.com. If you are a member of the Class, in order to share in the distribution of the Net Settlement Fund, you must either submit a Proof of Claim online at www.cmlsiiistockholdersettlement.com by <strong>May 25, 2026</strong> or by mail to be received no later than <strong>May 25, 2026</strong>, establishing that you are entitled to a recovery.1</p>
<div class="lb-trans"><p>如果您在 2021 年 12 月 14 日持有 CMLS III A 类普通股，无论是记录持有还是实益持有，您的权利可能会受到本诉讼和解的影响。如果您尚未收到详细通知和索赔及解除证明表（&#34;索赔证明&#34;）的副本，您可以通过写信至 CMLS III 股东和解，和解管理员，JND 法律管理，邮政信箱 91222，西雅图，WA 98111，或在 www.cmlsiiistockholdersettlement.com 下载此信息来获取副本。如果您是集体成员，为了分享净和解基金的分配，您必须在 <strong>2026 年 5 月 25 日</strong> 之前在线提交索赔证明，或通过邮寄方式在 <strong>2026 年 5 月 25 日</strong> 之前送达，以证明您有权获得赔偿。1</p>
</div><p>The Class is a non-&#34;opt-out&#34; class pursuant to Court of Chancery Rules 23(a), 23(b)(1), and 23(b)(2). Accordingly, Class Members will be bound by any judgment entered in the Action pursuant to the terms and conditions of the Stipulation.</p>
<div class="lb-trans"><p>该集体是根据衡平法院规则 23(a)、23(b)(1) 和 23(b)(2) 的非&#34;选择退出&#34;集体。因此，集体成员将受限于根据协议条款和条件在诉讼中作出的任何判决。</p>
</div><p>Any objection to the Settlement must be filed with the Register in Chancery at the address set forth below and served on Plaintiffs' Counsel and Defendants' Counsel (electronically by File &amp; Serve <em>Xpress</em>, by hand, by first-class U.S. mail, by express service, or by email) at the addresses below, such that it is received no later than <strong>April 7, 2026</strong>:</p>
<div class="lb-trans"><p>对和解的任何异议必须在以下地址向衡平法院登记处提交，并送达原告律师和被告律师（通过 File &amp; Serve _Xpress_电子方式、亲自、通过美国邮政一类邮件、快递服务或电子邮件）至以下地址，确保在 <strong>2026 年 4 月 7 日</strong> 之前收到：</p>
</div><p><strong>REGISTER IN CHANCERY</strong></p>
<div class="lb-trans"><p><strong>衡平法院登记处</strong></p>
</div><p>Register in Chancery</p>
<div class="lb-trans"><p>衡平法院登记处</p>
</div><p>Court of Chancery of the State of Delaware</p>
<div class="lb-trans"><p>特拉华州衡平法院</p>
</div><p>Leonard L. Williams Justice Center</p>
<div class="lb-trans"><p>莱昂纳德·L·威廉姆斯司法中心</p>
</div><p>500 North King Street</p>
<div class="lb-trans"><p>北金街 500 号</p>
</div><p>Wilmington, DE 19801</p>
<div class="lb-trans"><p>威尔明顿，DE 19801</p>
</div><p><strong>PLAINTIFF'S COUNSEL</strong></p>
<div class="lb-trans"><p><strong>原告律师</strong></p>
</div><p>Gregory E. Del Gaizo</p>
<div class="lb-trans"><p>格雷戈里·E·德尔·盖佐</p>
</div><p>Robbins LLP</p>
<div class="lb-trans"><p>罗宾斯律师事务所</p>
</div><p>5060 Shoreham Place, Suite 300</p>
<div class="lb-trans"><p>5060 Shoreham Place, Suite 300</p>
</div><p>San Diego, CA 92122</p>
<div class="lb-trans"><p>圣地亚哥，CA 92122</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>Kelly L. Tucker</p>
<div class="lb-trans"><p>凯莉·L·塔克</p>
</div><p>Grant &amp; Eisenhofer P.A.</p>
<div class="lb-trans"><p>格兰特与艾森霍弗律师事务所</p>
</div><p>123 Justison Street, 7th Floor</p>
<div class="lb-trans"><p>德拉瓦州威明顿市 123 Justison Street, 7 楼</p>
</div><p>Wilmington, DE 19801</p>
<div class="lb-trans"><p>邮政编码 19801</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p><strong>DEFENDANTS' COUNSEL</strong></p>
<div class="lb-trans"><p><strong>被告律师</strong></p>
</div><p>Deborah S. Birnbach</p>
<div class="lb-trans"><p>德博拉·S·伯恩巴赫</p>
</div><p>Goodwin Procter LLP</p>
<div class="lb-trans"><p>Goodwin Procter LLP</p>
</div><p>100 Northern Avenue</p>
<div class="lb-trans"><p>北大道 100 号</p>
</div><p>Boston, MA 02210</p>
<div class="lb-trans"><p>马萨诸塞州波士顿 02210</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>Gregory Starner</p>
<div class="lb-trans"><p>格雷戈里·斯塔纳</p>
</div><p>1221 Avenue of the Americas</p>
<div class="lb-trans"><p>美洲大道 1221 号</p>
</div><p>New York, New York 10020</p>
<div class="lb-trans"><p>纽约市，纽约州 10020</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p><strong>PLEASE DO NOT CONTACT THE COURT, THE REGISTER IN CHANCERY, DEFENDANTS, OR DEFENDANTS' COUNSEL REGARDING THIS NOTICE</strong>. If you have any questions about the Settlement, you may contact counsel for Plaintiffs at the addresses listed above, call (302) 622-7000, or (619) 525-3990, or go to the following website: www.cmlsiiistockholdersettlement.com.</p>
<div class="lb-trans"><p><strong>请勿就此通知联系法院、注册官、被告或被告律师</strong>。如果您对和解有任何疑问，可以通过上述地址联系原告的律师，拨打电话 (302) 622-7000 或 (619) 525-3990，或访问以下网站：www.cmlsiiistockholdersettlement.com。</p>
</div><p>BY ORDER OF THE COURT OF CHANCERY</p>
<div class="lb-trans"><p>根据德拉瓦州衡平法院的命令</p>
</div><p>OF THE STATE OF DELAWARE</p>
<div class="lb-trans"><p>1 证明索赔的邮戳日期不得晚于 <strong>2026 年 5 月 25 日</strong>，将视为在邮戳日期收到。请注意，美国邮政服务可能不会对未亲自递交的邮件进行邮戳。</p>
</div><p>1 Proofs of Claim that are legibly postmarked no later than <strong>May 25, 2026</strong> will be treated as received on the postmark date. Please be advised that the U.S. Postal Service may not postmark mail which is not presented in person.</p>
<p>SOURCE JND Legal Administration</p>
<div class="lb-trans"><p>来源 JND 法律行政管理</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjEzJk5ld3NJdGVtSWQ9TEE3NjgzOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMTMwOTEzUFJfTkVXU19VU1BSX19fX19MQTc2ODM4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA76838&amp;Transmission_Id=202602130913PR_NEWS_USPR_____LA76838&amp;DateId=20260213"/></p>

09:13 ETNotice of Pendency and Proposed Settlement of Stockholder Class Action Involving All Record and Beneficial Holders of CM Life Sciences III, Inc. Class A Common Stock on December 14, 2021

prnewswire

Origin Life Sciences

Caris Life Sciences

MDNA Life Sciences, Inc.

关于 CM Life Sciences III, Inc. A 类普通股的股东集体诉讼的待决通知和拟议和解，涉及所有在2021年12月14日持有记录和受益的股东